Kenneth Bate - Insider Trading & Ownership

Entity
Individual
Location
C/O Millennium Pharmaceuticals Inc, 40 Landsdowne Street, Cambridge, Massachusetts
Summary
The estimated net worth of Kenneth Bate is at least $564K dollars as of June 27, 2024. Kenneth Bate is the Director of MADRIGAL PHARMACEUTICALS, INC. and owns shares of MADRIGAL PHARMACEUTICALS, INC. (MDGL) stock worth about $535K. Kenneth Bate is the Director of Epizyme, Inc. and owns shares of Epizyme, Inc. stock worth about $23K. Kenneth Bate is the Director of AVEO PHARMACEUTICALS, INC. and owns shares of AVEO PHARMACEUTICALS, INC. stock worth about $5.63K.
All Insider Reports
All Insider Reports

Ownership of Kenneth Bate

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
MDGL MADRIGAL PHARMACEUTICALS, INC. Director $535K -$8.21M -93.9% Jun 25, 2024
EPZM Epizyme, Inc. Director $23K Aug 12, 2022
AVEO AVEO PHARMACEUTICALS, INC. Director $5.63K Jan 19, 2023
ATXS Astria Therapeutics, Inc. Director Jun 5, 2024
GNCA GENOCEA BIOSCIENCES, INC. Director Jul 1, 2021

Insider Transactions Reported by Kenneth Bate:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.